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Abstract: The extracellular matrix (ECM) plays a key role in the modulation of cancer cell invasion. In urothelial carcinoma 
of the bladder (UC) the role of ECM proteins has been widely studied. The mechanisms, which are involved in the develop-
ment of invasion, progression and generalization, are complex, depending on the interaction of ECM proteins with each 
other as well as with cancer cells. The following review will focus on the pathogenetic role and prognostic value of structural 
proteins, such as laminins, collagens, ﬁ  bronectin (FN), tenascin (Tn-C) and thrombospondin 1 (TSP1) in UC. In addition, 
the role of integrins mediating the interaction of ECM molecules and cancer cells will be addressed, since integrin-mediated 
FN, Tn-C and TSP1 interactions seem to play an important role during tumor cell invasion and angiogenesis.
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Introduction
Originally the extracellular matrix (ECM) was seen as “glue” between other important elements, but 
proved to be a dynamic structure, playing a key role in fetal development, tissue repair and angiogen-
esis as well as in modulation of cancer cell invasion (Bosman and Stamenkovic, 2003). The ECM 
constitutes of structural proteins, such as collagens, elastin, laminins and glycoproteins such as ﬁ  bro-
nectin (FN), vitronectin and tenascin (Tn-C) and a variety of other proteins including proteolytic enzymes 
such as matrix metalloproteinases and their inhibitors as well as proteoglycans (Bosman and Stamenkovic, 
2003). In the progression to invasive cancer, complex interactions are necessary to pass the basal mem-
brane, invade the surrounding tissue and vessel walls. In all these processes, the ECM is critically 
involved (Bosman and Stamenkovic, 2003).
In the normal urinary bladder, structural proteins of the wall are necessary to maintain the 
integrity of the impermeable bladder surface (Wilson et al. 1996). Disturbance of these proteins 
has been suggested to be involved in inflammatory conditions (Deen et al. 1994). In urothelial 
carcinoma of the bladder (UC), the role of ECM proteins has been widely studied to assess inva-
sive behavior. Gene expression in bladder cancer cell lines has been shown to depend on the 
matrix used for cultivation (Deen et al. 1994; Ioachim et al. 2005; Dozmorov et al. 2006). The 
following review will focus on the role of structural proteins in UC, which have been suggested 
to be of prognostic value (Table 1).
Extracellular Matrix in Urothelial Bladder Cancer
Laminin
Laminin is one of the most important components of the basal membrane. First described 20 years ago, 
15 distinct laminin isoforms have been isolated so far (Bosman and Stamenkovic, 2003). The molecule 
is built of three disulﬁ  de-linked chains, including ﬁ  ve α, three β and three γ isoforms, with a character-
istic cross shape (Bosman and Stamenkovic, 2003). Laminin is produced by nearly all epithelial-, smooth 
muscle-, cardiac muscle-, nerve- and endothelial cells (Bosman and Stamenkovic, 2003). Functionally, 
depending on the isoforms expressed, laminins are involved in cell proliferation, adhesion and migration 
(Engbring et al. 2003). Their effects are mediated through binding to integrins and their most important 419
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function seems to be the interaction between epi-
thelial cells and the ECM (Syrigos et al. 1999; 
Bosman and Stamenkovic, 2003). The role of 
laminins in cancer has been excessively studied and 
it has been shown that aberrant synthesis, chain 
composition and proteolytic modiﬁ  cation are impor-
tant for the interaction between malignant cells and 
ECM (Pattarroyo et al. 2002).
In UC of the bladder, the distribution of laminins 
has been studied in order to assess inﬁ  ltrative 
behavior, to detect early invasion and to evaluate 
the presence of tumor-derived basal membranes 
(Conn et al. 1987; Schapers et al. 1990; Abou Fahra 
et al. 1993). Several studies focused on the useful-
ness of immunohistochemical staining for basal 
membrane components and their prognostic sig-
niﬁ  cance (Conn et al. 1987; Schapers et al. 1990; 
Abou Fahra et al. 1993). Schapers et al. found a 
signiﬁ  cant association between the presence of 
intact basal membranes and stage (Schapers et al. 
1990). In cases where stage could not be deter-
mined on hematoxylin and eosin stained slides, 
staining for basal membrane components proved 
to be helpful in determining the correct stage 
(Schapers et al. 1990). Recurrence-free survival 
was not inﬂ  uenced by these ﬁ  ndings, though a 
tendency towards a higher risk of progression and 
worse overall survival for patients, whose tumors 
showed disrupted basal membranes, was reported 
(Schapers et al. 1990). Interestingly, some clearly 
invasive tumors in this study showed an intact basal 
membrane (Schapers et al. 1990). It was therefore 
suggested, that a positive relation between break-
down and deposition of basal membrane compo-
nents probably reﬂ  ects an intact host response to 
the neoplasm (Conn et al. 1987; Schapers et al. 
1990). In fact, the basal membrane is not a static, 
but a dynamic structure, characterized by constant 
deposition and degradation of its components 
(Schapers et al. 1990). Alampi et al. observed a 
worse overall survival for patients with loss or 
fragmentation of the basal membranes compared 
to those with intact basal membranes (Alampi et al. 
1989). Abou Fahra et al. found a higher recurrence 
rate and shorter recurrence-free survival for 
patients with disrupted basal membranes; those 
with lost stainable basal membranes around vessels 
more commonly developed metastatic disease 
(Abou Fahra et al. 1993). On the other hand, 
Ioachim et al. evaluated the distribution of ECM 
components in bladder cancer and reported that 
the expression of laminin did not contribute to 
recurrence and progression in UC (Ioachmin et al. 
2005).
Laminins are a heterogeneous group of proteins 
with different isoforms, which mediate a diversity 
of functions (Hindermann et al. 2003). One iso-
form, involved in the formation of hemidesmo-
somes in basal epithelial cells that was identiﬁ  ed 
to be of importance for cellular adhesion and 
migration, was laminin-5 (Hindermann et al. 
2003). The function of laminin-5 is known to 
depend on proteolytic processing through plasmin 
and matrix metalloproteinases (Bosman and Sta-
menkovic, 2003). In fact, the γ2 chain, unique to 
laminin-5, proved to be of importance for the 
migration and cell adhesion of malignant tumors 
(Gianelli et al. 2001; Hindermann et al. 2003). 
Several studies assessed the value of the γ2 chain 
in different tumor types, with both reported losses 
as well as increased expression (Sordat et al. 1998; 
Kosmehl et al. 1999; Ono et al. 1999; Skyldberg 
et al. 1999; Henning et al. 1999; Gianelli et al. 
2001; Hao et al. 1996). The γ2 chain was found to 
be expressed in ECM also outside the basal mem-
brane and to be retained in tumor cells of superﬁ  -
cial UC, while in invasive tumors, loss of basal 
membrane staining was evident (Hindermann et al. 
2003). These ﬁ  ndings were associated with a worse 
overall survival, but independent prognostic sig-
niﬁ  cance was not reached. This altered distribution 
suggests a failure to form anchoring ﬁ  laments and 
hemidesmosomes allowing carcinoma cell inva-
sion (Hindermann et al. 2003). Furthermore, in 
patients treated with transurethral resection (TUR), 
but not cystectomy, the deposition of γ2 chain of 
laminin-5 proved to be an independent prognostic 
factor indicating a higher risk of recurrence (Kiy-
oshima et al. 2005). The expression of γ2 chain 
was not inﬂ  uenced by the expression of epidermal 
growth factor receptor (EGFR) and human epider-
mal growth receptor 2 (HER2/neu) as well as 
cyclooxygenase 2, which have also been found to 
be associated with more aggressive UC behavior 
and probably directly interact with the γ2 chain 
(Kiyoshima et al. 2005). Further, particularly pro-
spective, studies should provide additional infor-
mation on the interactions and functions of the γ2 
chain in UC in order to establish its diagnostic, 
prognostic and predictive signiﬁ  cance.
Collagens
Collagens play an important role as a scaffold
in maintaining tissue structure (Bosman and 421
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Stamenkovic, 2003). Collagens are either organized 
as ﬁ  brils in tissues that are exposed to shear, tensile 
or pressure forces including tendons, bone cartilage 
and skin, or are able to form networks, such as 
collagen IV, which is an important component of 
the basal membrane (Bosman and Stamenkovic, 
2003). Collagens are usually synthesized by 
mesenchymal cells, such as fibroblasts and 
myoﬁ  broblasts, but collagen IV is also produced by 
adjacent epithelial cells (Bosman and Stamenkovic, 
2003). In hollow organs, the most important inter-
stitial collagens include collagens III and I (Bosman 
and Stamenkovic, 2003). In the normal bladder wall, 
these two types are mainly expressed in the lamina 
propria and around smooth muscle bundles and 
nerves (Wilson et al. 1996). Interstitial collagens 
have been suggested to be involved in rat bladder 
cancer cell lines single cell inﬁ  ltration (Tucker et al. 
1990). The role of collagens in UC has not been 
extensively studied, except for collagens IV and VII, 
known to be basal membrane components; collagen 
VII playing a role in the formation of hemidesmo-
somes with the basal cells of the urothelium (Daher 
et al. 1987; Schapers et al. 1990; Liebert et al. 1994). 
Similar to laminin, collagen IV staining was used 
to assess the presence of early invasion (Daher et al. 
1987; Schapers et al. 1990). The loss of collagen IV 
expression in the basal membrane was reported to 
be associated with a worse overall survival and a 
tendency towards progression, but no inﬂ  uence on 
recurrence-free survival could be detected (Schapers 
et al. 1990). Daher et al. investigated collagen IV 
staining pattern in a group of invasive cancers and 
found that widely absent or fragmented staining in 
more than 5% of a tumors predicted a worse short 
term survival (Daher et al. 1987). Özer et al. focused 
on high grade pT1 tumors and found that collagen 
IV did not play a role in predicting behavior (Özer 
et al. 1999). It is difﬁ  cult to assess if collagen IV 
can be helpful in evaluating the correct tumor stage, 
since it may be absent in urothelium with substantial 
superﬁ  cial inﬂ  ammation, a condition that can also 
accompany carcinoma in situ and papillary neo-
plasms (Deen et al. 1994). Collagen VII has been 
studied in UC together with the expression of inte-
grin α6β4, which is, in normal urothelium, 
co-localized with collagen VII (Liebert et al. 1994). 
Loss of this co-localization has been found and the 
degree of de-arrangement increased in invasive 
cancers, suggesting involvement during invasion 
(Liebert et al. 1994). Since its particular sensitivity 
to inﬂ  ammatory conditions, alteration of collagen 
stainability could be of little practical importance 
concerning diagnosis and prognosis of UC.
Fibronectin
Fibronectin (FN) is a non-collagenous glycoprotein 
with a distinct tissue distribution, predominantly 
localized in mesenchymal tissues (Ioachim et al. 
2005). Similar to laminin, FN plays a role in cell 
adhesion, proliferation and migration (Ioachim et al. 
2005). The distribution of FN in the normal bladder 
wall and in UC has been described by few authors 
(Deen and Ball, 1994; Wilson et al. 1996). The 
normal bladder wall revealed no consistent staining 
in the urothelium, though some superﬁ  cial urothelial 
cells were positive (Wilson et al. 1996). Staining in 
the lamina propria was present and enhanced just 
beneath the basal membrane as well as surrounding 
individual muscle ﬁ  bers and in vessel walls (Wilson 
et al. 1994). FN staining in UC appeared to be 
intense around invasive tumors cells nests, while in 
non-invasive tumors staining seemed to be more 
heterogeneous and mostly enhanced in the lamina 
propria, but only faintly present in the tumor papil-
lary cores (Deen et al. 1994; Ioachim et al. 2005). 
Data on the prognostic value of FN in UC are scarce. 
Ioachim et al. found that expression of FN was 
associated with tumor stage, proliferation index, 
laminin, collagen IV, tenascin C (Tn-C), and 
microvessel density, suggesting that FN is associated 
with proliferation, invasion and angiogenesis 
(Ioachim et al. 2005). In fact, it is well known that 
FN interacts with Tn-C, which modulates FN-
dependent adhesions, thus probably contributing to 
invasive behavior (Huang et al. 2001). FN staining 
in the study of Ioachim et al. was not associated with 
progression or recurrence (Ioachim et al. 2005). The 
putative value of FN was otherwise only assessed 
in urine or blood of UC patients as well as in tissue 
homogenates of tumors. Kirkali et al. found an 
increase of FN in tissue homogenates of patients 
with UC, when compared to healthy controls 
(Kirkali et al. 2001). Some studies focused on FN 
levels in urine (Malmstrom et al. 1993; Menendez 
et al. 2005). In the presence of malignant tumors, 
the components of the ECM are degraded by pro-
teases during invasion (Menendez et al. 2005). 
Antibodies against speciﬁ  c cell binding domains of 
FN allow the detection of fragments in urine (Kata-
yama et al. 1991, 1993). It has been reported that 
cancer patients have increased levels of urinary FN 
compared to healthy persons (Katayama et al. 1991, 
1993). For this purpose, an automatic assay called 422
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bladder tumor ﬁ  bronectin (BTF) was developed 
(Katayama et al. 1991; Menendez et al. 2005). 
Menendez et al. performed a prospective study in 
123 patients to evaluate the diagnostic accuracy of 
BTF (Menendez et al. 2005). They reported that 
levels of urinary FN were substantially elevated in 
patients with UC compared to healthy controls, but 
the test was limited by lack of sensitivity in low 
grade tumors as well as lack of speciﬁ  city in patients 
with infections of the lower urinary tract, benign or 
malignant prostatic disease, urinary stones or after 
endovesical chemotherapy (Menendez et al. 2005). 
Malmstrom et al. found decreased urinary FN after 
transurethral tumor resection as well as in patients 
with response after Bacillus Calmette-Guérin 
(BCG)-treatment suggesting that urinary FN might 
be helpful in selecting patients for further BCG-
therapy (Malmstrom et al. 1993). On the other hand, 
Danisman et al. reported that urinary FN is of no 
additional value in patients treated with BCG (Dan-
isman et al. 2000).
Due to low sensitivity, determination of FN in 
plasma of UC patients did not prove to be helpful 
(Hegele et al. 2003). Indeed, the main percentage 
of FN in the blood is synthesized by hepatocytes, 
but one distinct form the so called cellular ﬁ  bronec-
tin (cFN) is derived from other cells and has a 
speciﬁ  c domain created by alternative mRNA splic-
ing by which it can be detected in plasma (Hegele 
et al. 2003). Hegele et al. studied cFN in urine and 
blood from 20 UC patients and 20 controls using a 
highly sensitive time resolved ﬂ  uorescence immu-
noassay (TRIFA) (Hegele et al. 2003). cFN levels 
in plasma were significantly higher in cancer 
patients compared to controls and differences were 
also detected between pTa/pT1 and pT2-4 tumors 
(Hegele et al. 2003). The value of FN in the urine 
and blood of UC patients still remains controversial. 
Possible reasons include the different methods used 
as well as the fact, that different FN types were 
measured including probably also abnormal forms, 
as demonstrated in other cell systems (Hegele et al. 
2003). Therefore, though FN seems to be a promis-
ing marker, its value in the detection and follow-up 
of UC still needs prospective evaluation.
Tenascin
Tn-C is a glycoprotein of the ECM, which is 
prominently expressed in developing tissues 
(Chiquet-Ehrisman and Chiquet, 2003). In adult 
tissues, expression of Tn-C is more restricted, but 
increases during processes associated with ECM 
remodeling such as inﬂ  ammation and carcinogenesis 
(Chiquet-Ehrismann and Chiquet, 2003).
Tn-C is composed of six identical subunits, 
which are disulﬁ  d-linked, forming a large six-
armed molecule. Subunits are built of repeated 
domains including epithelial growth factor-like 
repeats, heptad repeats, ﬁ  bronectin III (FNIII) 
repeats and C-terminal globular domains shared 
with fibrinogen. Alternative splicing of Tn-C 
results in many different forms containing variable 
numbers of additional FNIII repeats (Chiquet 
Ehrismann and Chiquet, 2003). Functionally, Tn-C 
is involved in cell adhesion, migration and growth 
through the interaction with FN-dependent cell 
adhesion (Huang et al. 2001). Tn-C binds to the 
FN and syndecan-4, which is necessary for the cells 
to fully spread on FN (Huang et al. 2001). By 
interfering with the binding to FN, Tn-C prevents 
the interaction of cells with FN in synergy with 
integrin α5β1 (Huang et al. 2001; Chiquet-Ehris-
man and Chiquet, 2003) (Figure 1).
In malignant tumors, the role of Tn-C is still 
under investigation and observations from studies 
on different tumor types remain conﬂ  icting, most 
likely as a result of the different Tn-C functions 
depending on different splicing variants and com-
plex interactions (Brunner et al. 2004; Berndt et al. 
2006). Tn-C expression has been reported at the 
invasive border of malignant tumors and was sug-
gested to be of prognostic signiﬁ  cance in several 
tumor types (Aishima et al. 2003; Wiksten et al. 
2003). In the normal bladder, Tn-C was found in 
the superﬁ  cial urothelial cells and the basal mem-
brane (Wilson et al. 1994; Booth et al. 2002). Weak 
staining was also observed in the lamina propria 
and around vessels (Deen et al. 1994; Booth et al. 
2002). UCs show an increase of Tn-C expression 
around invasive tumor cell nests as well as in the 
papillary cores and increased staining has been 
linked to tumor grade and stage (Tiita et al. 1993; 
Booth et al. 2002). So far, little data are available 
on the prognostic signiﬁ  cance of Tn-C in UC.
In a retrospective study, we analyzed 106 UCs 
and showed that the staining performance for Tn-C 
of the tumor cells and stroma had a prognostic sig-
niﬁ  cance, depending on the speciﬁ  c microarchitec-
tural localization and the pattern of Tn-C expression 
(Brunner et al. 2004). A diffuse Tn-C staining in the 
stroma of invasive tumors was associated with a 
signiﬁ  cantly worse prognosis (Brunner et al. 2004). 
Beside stromal Tn-C expression, cytoplasmatic 
staining in superﬁ  cial and invasive tumor cells was 423
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observed in this study (Brunner et al. 2004). The 
main source of Tn-C are stromal ﬁ  broblasts, though 
it has been shown that tumor cells are able to syn-
thesize large amounts of Tn-C (Booth et al. 2002). 
The value of cytoplasmatic Tn-C remains question-
able. We observed a better overall survival for 
patients with cytoplasmatic staining and a negative 
correlation between stromal and cytoplasmatic Tn-
C (Brunner et al. 2004). We therefore suggest that 
the differences between stromal and cytoplasmatic 
Tn-C expression are probably due to different splic-
ing variants of Tn-C, generating functional diversity 
with different effects on cell proliferation and migra-
tion. In breast cancer, Adams et al. found that dif-
ferent isoforms of Tn-C are expressed and that two 
isoforms (Tn16 and Tn14/16), exclusively synthe-
sized in the stromal compartment, may be helpful 
in predicting invasion (Adams et al. 2001). Berndt 
at al. evaluated 34 UCs and found that, depending 
on the tumor type, invasive behavior and vascular-
ization, different Tn-C splicing variants were 
expressed (Berndt et al. 2006). They suggested that 
this could be helpful in the assessment of invasion 
and could serve as target for antibody-mediated 
therapy (Berndt et al. 2006). In addition, they 
reported on speciﬁ  c splicing variants of Tn-C that 
were associated with newly formed vessels, further 
supporting the hypothesis that Tn-C plays a role in 
angiogenesis (Berndt et al. 2006). In fact, in vitro 
studies showed that endothelial cells spread on Tn-
C via binding to integrins α2β1 and αVβ3 (Srira-
marao et al. 1993). Tn-C expression in UC with 
particular emphasis on pattern and distribution may 
add prognostic information, though its role in 
tumorigenesis and progression of bladder cancer 
still requires further investigation.
Other ECM molecules
A variety of other ECM molecules have been 
described in the human bladder, though data on 
their pathogenetic role and prognostic value in UC 
are scarce. These include vitronectin, elastin, and 
proteases other than matrix metalloproteinases, 
such as tetranectin (Wilson et al. 1996; Brunner 
et al. 2007).
One glycoprotein that has evoked increasing 
interest in UC of the bladder is thrombospondin 1 
(TSP1) (Ioachim et al. 2006). TSP1 is a glycopro-
tein of the ECM known to be a potent inhibitor of 
angiogenesis (Ioachim et al. 2006). Immunohisto-
chemical expression of TSP1 has been evaluated 
in UC of the bladder and was reported to predict 
recurrences and overall survival (Grossfeld et al. 
1997; Goddard et al. 2002). Grossfeld et al. reported 
that low TSP1 was associated with high microves-
sel density, shorter recurrence-free survival and 
Figure 1. Scheme of extracellular matrix components potentially deregulated in invasive urothelial carcinoma of the bladder.424
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worse overall survival in a study including 163 UC 
patients (Grossfeld et al. 1997). They further found 
that the anti-angiogenic effect may be at least partly 
regulated by p53 (Grossfeld et al. 1997). Indeed, 
tumors with p53 accumulation were more likely to 
have reduced levels of TSP1 (Grossfeld et al. 1997). 
Goddard et al. found that loss of TSP1 was an 
independent prognostic factor indicating a worse 
overall survival (Goddard et al. 2002). In vitro stud-
ies have shown that TSP1 inhibits angiogenesis 
induced by a bladder cancer cell line and that TSP1, 
together with Tn-C, modulates sprouting of endo-
thelial cells (Canﬁ  eld et al. 1995; Campbell et al. 
1998). Tn-C induces a sprouting phenotype inhib-
ited by TSP1. Evaluation of FN, Tn-C and TSP1 in 
UC of the bladder showed a correlative expression, 
suggesting probable retained interactions between 
these ECM molecules during tissue remodeling 
(Ioachim et al. 2006). In contrast to previous results, 
Ioachim et al. reported a positive correlation of 
TSP1 with microvessel density and vascular endo-
thelial growth factor (Ioachim et al. 2006). TSP1 
may have inhibitory as well as enhancing effects 
on angiogenesis (Canfield et al. 1995). These 
effects, similarly to other ECM molecules, may 
largely depend on the composition of the surround-
ing matrix reﬂ  ected by the association of TSP1 
expression with FN and Tn-C.
Integrins
Integrins are adhesion molecules that play a crucial 
role in the interaction between epithelial cells and 
ECM components as well as between different ECM 
proteins (Syrigos et al. 1999). De-arrangement, loss 
and shift of integrin expression are known to play 
an important role in the development of invasion of 
malignant tumors including UC of the bladder (Bos-
man and Stamenkovic, 2003; Syrigos et al. 1999). 
The most important ECM molecules, already dis-
cussed in this review, and their binding integrins 
including the proposed involvement in UC are sum-
marized in Table 2. Integrins are transmembrane 
glycoproteins composed of non-covalently associ-
ated α/β heterodimers, made up of 15α and 9β 
chains (Bosman and Stamenkovic, 2003). Combina-
tions of chains allow the formation of a wide range 
of different integrin molecules (Bosman and Sta-
menkovic, 2003). Integrins are found in all cells and 
are necessary for tissue structure maintenance (Bos-
man and Stamenkovic, 2003). They mainly function 
as receptors for ECM proteins, including laminin, 
collagen VII, FN, Tn-C, vitronectin and TSP1 (Syri-
gos et al. 1999). Some integrins bind only one 
speciﬁ  c ligand, while others have a variety of pos-
sible ligands (Syrigos et al. 1999). Differences in 
binding speciﬁ  city may depend on the cell type by 
which the integrin is expressed. The normal bladder 
urothelium expresses α3, αV, β1 and β4, all being 
important for impermeability maintaining of the 
bladder wall (Wilson et al. 1996; Syrigos et al. 
1999). α3-integrin has been suggested to be involved 
in the modulation of the expression of other integrin 
receptors in bladder cancer (Litynska et al. 2002).
De-arrangement of α6β4-integrin in bladder 
cancer was shown to be associated with invasive 
behavior, since its loss impairs tumor cell binding 
to the collagen VII basal membrane component 
(Liebert et al. 1994). It has been suggested that this 
is an early event in UC. Indeed, expression of 
integrins in UC becomes aberrant and deregulated 
with increasing grade and stage (Syrigos et al. 
1999). Reduction of expression of integrin β4 has 
been found to correlate with an increased intraep-
ithelial spread of tumors cells on laminin 
(Harabayashi et al. 1999). β1-integrin was reported 
to be critically involved in adhesion, extravasation 
and migration of an invasive bladder cancer cell 
line (Heyder et al. 2005).
Integrins are known to interact with ECM mol-
ecules such as FN and Tn-C (Syrigos et al. 1999). 
The function of FN is mediated by α5β1-integrin 
and syndecan-4, acting simultaneously (Huang 
et al. 2001). Tn-C interferes with syndecan-4 and 
prevents the FN-dependent adhesion and thus 
enhances proliferation. This ﬁ  nding as well as the 
increased expression of Tn-C and FN in the ECM 
of UC, suggests that the interaction between these 
two molecules is important for tissue remodeling 
in UC (Huang et al. 2001). Finally, integrins are 
involved in the sprouting of endothelial cells on 
Tn-C, suggesting that they are possible co-factors 
contributing to the angiogenic function of Tn-C, 
though so far studies in UC have not been per-
formed (Sriramarao et al. 1993). All these ﬁ  ndings 
point to the importance of an integrative approach 
for the elucidation of the role of ECM molecule 
expression in UC, considering also the impact of 
their associated receptor molecules.
Perspectives
In UC of the bladder the most important prognos-
tic factors still are based on morphology, including 425
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tumor size, multiplicity, associated carcinoma in 
situ, grade and stage (Rodriguez-Alonso et al. 
2002). New prognostic factors including also ECM 
molecules could be of importance in estimating 
the risk of patients for relapse and muscle-invasive 
disease. In addition, the ECM in UC may be a 
potential therapeutic target for treatment in UC. 
Indeed, targeting the ECM, one can expect to by-
pass the treatment-resistance mechanisms of tumor 
cells. However, genetic changes have also been 
identiﬁ  ed in the stroma surrounding tumor cells in 
mammary cancer and colonic polyps, and tumor 
cells can develop genetic alterations resulting in 
reduced stromal dependence (De Wever et al. 
2003). Further investigations to better understand 
the stromal contribution on growth promotion, 
de-differentiation and invasion of urothelial 
carcinoma cells will be necessary to detailedly 
elucidate the complex role of ECM in UC.
Summary
To summarize, ECM molecules in UC of the bladder 
seem to play an important role in the development of 
invasion, progression and metastasis. The mechanisms 
involved are complex, depending on the interaction 
of ECM proteins with each other as well as with can-
cer cells. Further studies, especially on FN, Tn-C and 
TSP1 and their interactions, mediated by integrins, 
are necessary to elucidate the different roles of these 
ECM components during tumor invasion and angio-
genesis, providing new insights in carcinogenesis and 
probably leading to new therapeutic approaches.
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